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Summary: A new, simple and sensitive method is described for assay of serum γ-glutamyltransferase activity based on
the hydrolysis of the substrate Z,-7-glutamyl-3-carboxy-4-nitranilide which offers the advantage of producing directly its
own chromogen.
The substrate is highly soluble and the method can therefore easily be adapted to any equipment for the automated
assay of γ-glutamyltransferase.
The activities at measured optimum substrate concentration are slightly higher than with the Szasz ((1969), Clin.
Chem. 15,124—136) method in which i-glutamyl-p-nitroanilide is used as substrate.
Eine neue Methode zur Bestimmung der y-Glutamyltfansferase im Serum
Zusammenfassung: Es wird eine einfache und empfindliche neue Methode f r die Bestimmung der γ-Glutamyltrans-
ferase-Aktivit t im Serum beschrieben. Sie beruht auf der Hydrolyse des Substrats Z,-7-Glutamyl-3-carboxy-4-nitranilid.
Die Freisetzung von 3-Carboxy-4-nitroanilin wird kontinuierlich bei 405 nm gemessen.
Das Substrat ist sehr gut l slich. Die Methode kann daher vorz glich auf alle automatischen Analysen-Ger te adaptiert
werden.
Bei Messung im Substrat-Optimum ergibt die neue Methode etwas (l,22fache) h here Werte als die bisher generell
verwendete Bestimmung der 7-Gl tamyltransferase nach&flsz ((1969), Clin. Chem. 15,124—136) mit L-Glutamyl-.
p-nitranilid als Substrat. Die Korrelatiofiskoeffizient beider Methoden betrug r = 0.999.
Introduction 3. A kinetic method has been described to study, in
T . Λ . u ~ . κΠΓ, ο ^ ο 0\ greater deal than for the other substrates, various factorsIn measuring serum T-glutamyltransferase (EC 2.3.2.2) , , , '
activity, the natural substrate glutathione was initially which influence 7-glutamyltransferase (6).
used (1). During the Sixties the synthetic substrates 4. Most of the more elaborate studies which have esta-
Ai^-glutamylaminoproprionitril (2), N-(Z),£-7- Wished the value of γ-glutamyltransferase assays in the
^utarnyl)aiiiline (3), £^-glutamyl-a-iiaphthylamide (4) diagnosis and therapeutic management of hepatobiliary
and i-y-gjutamyl-p-nitranilide (5) were proposed. Only disease, were performed with this substrate (7—16).
the last-mentioned of these substrates has been retained The use of Ζ-γ-glutamyl-p-nitrariilide poses practical
for routine use, for the following reasons: problems due to its poor solubility. In order to obtain
-
 VT ,,.,. , ., . .. . . A.. a substrate concentration which is close to optimal,1. No additional monitoring reaction is required to pro- , . , . , , ,. . . - ί / u- u
, , . ,- -xnu ι A - " * J f^ dissolution under heat application is required (which,duce a dye, as is the case with the cleavage products of the f r . n
 Λ
 v
- b t t however, promotes autolysis of the substrate); a pos-
er su s ra .
 s«^je alternative is dissolution in an acid medium
2. The molar absorptivity is sufficient (9.9 cm2//imol at followed by alkalization.
405 nm) for adequately exact measurement of the tran- Due to low solubility, i-y-glutamyl-p-nitranilide cannot
sitiori range between normal and pathological. be used with equipment which measures γ-glutamyl-
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transferase kinetically and starts the reaction by the
addition of a small volume of substrate solution.
These considerations prompted us to search for better
substrates. We first tested a few dipeptides but, because
the indicator reaction took an unfavourable course, we
switched to new synthetic substrates derived from
Ζ,-7-glutamyl-p-nitranilide, by derivatization of the
p-nitraniline moiety. Two of these (Z,-7-glutamyl-3^
carboxy-4-nitranilide and i-7-glutamyl-3-sulphonic-4-
nitranilide) proved to be very good substrates for
γ-glutamyltransferase with high turnover rates and more
than 50 times the solubility of Ζ,-γ-glutamyl-p-nitranilide,
and thus could be accepted as alternatives. Preliminary
communications announcing the applicability of these
substrates have already appeared (17,18). In our study
we established optimal conditions with these substrates,
and this paper describes a kinetic method using L-y-
glutamyl-3-carboxy-4-nitranilide.
Materials and Methods
The substrates /,-7-glutamyl-3-carboxy-4-nitranilide (Molecular
weight 345) and jL-7-glutamyl-3-sulphonic-4-nitranilide
(Molecular weight 382) and other derivatives from L-^-gluta-
myl-p-nitranilide, were synthesized by the Boehringer Mann-
heim Company, Tutzing, Germany.
Reagent
(buffered substrate solution)
Dissolve 12.917 g (106.7 mmol/1) Tris (hydroxymethyl) amino-
methane and 21.136 g (160.0 mmol/1) glycylglycine (Fluka) in
900 ml bidistilled water. Adjust the pH to 8.2 at 25°C. Add
2.208 g (6.4 mmol/1) L-7-glutamyl-3-carboxy-4-nitranilide
(ammonium salt with 1 mol H2O). The volume is made up
to 1000 ml with bidistilled water and is checked again to be 8.2.
The absorbance of the freshly prepared solution increases about
7% within 24 hours when stored at room temperature (this
corresponds to less than 1.0 U/l).
Procedure
Serum (0.2 ml) is added to buffered substrate (3.0 ml) equilibrated
to 25°C. The increase of absorbance at 405 nm in 1.0 cm light
path is recorded during 10 minutes immediately after mixing.
Calculation of activity
Activity (U/l) = ΔΑ/min Χ 1690
3.2 X 1000
The factor 1690 = is derived from:
0.2 X 9.49
3.2: total volume [ml]
1000: conversion to U/l
0.2: sample volume [ml]
9.49: molar absorptivity [cm2/Mmol] of 2 nitro-Samino-
benzoate
For calculation of activity it should be taken into account that
the increase of absorbance per minute at 405 nm (ΔΑ/min) is not
linear with time after 5 minutes reaction time for activities
higher than 200 U/l. Below 150 U/l the rate of the reaction is
linear during the first 10 minutes.
Apparatus
Measurements were performed with the Zeiss PMQII equipped
with an automatic slit control and T/A converter. The position
of the automatic slit control was taken by a cuvette filled with
buffered substrate.
Results
Preliminary experiments with dipeptides
Hanes et al. described Ζ-γ-glutamyl-i-glutamic acid as
substrate for γ-glutamyltraiisferase (I). Our expectation
was that the resulting glutamic acid could be simultane-
ously converted to ammonia by addition of the auxiliary
enzyme glutamate dehydrogenase. The NADH formed in
this reaction could be used to measure the γ-glutamyl-
transferase by continuous monitoring of the reaction at
340 nm. Leucine, added s acceptor (1) could act as
stabilizer for glutamate dehydrogenase, as suggested by
Persijn et al. (19). Unfortunately, the indicator reaction
was rate-limiting; this was also the case with the alter-
native substrate i-y-glutamyl-D-alanine. Here, the plan
was to couple the liberation of Z)-alanine to its deamina-
tion by /^arnino acid oxidase, foDowed by reduction by
lact te dehydrogenase in the presence of NADH.
Preliminary experiments with substrates derived
from Ζ,-γ-glutamyl-p-nitranilide
A number of substrates derived from Ζ,-γ-glutamyl-p-
nitranilide by introduction of hydrophilic groups or
alteration of the benzene ring were tested for solubility
and suitability as substrate for measuring γ-glutamyl-
transferase. The results of these tests are presented in
table 1. Relative activities were determined without
accounting for possible differences in optimal concen-
tration between the various substrates.
The results encouraged us to continue the study with
the compounds that have a carboxyl or sulphonyl group
on the 3 position. The favourable spectral properties of
both substrates and their cleavage products were an
additional argument for further investigation. The shape
of the spectrum of the cleavage products of Ζ,-γ-glutamyl-
p-nitranilide, £-7-glutamyl-3-carboxy-4-nitranilide, and
Z,-7-glutamyl-3-sulphonic4-nitranilide is the same. How-
ever, the 2^nitro-5-amino-benzenesulphonic acid shows a
significantly lower absorbance at 405 nm than the other
two compounds. The molar absorptivities of 2-nitro-5-
aminobenzoic acid and 2-nitro-5-aminobenzenesulphonic
acid at 405 nm are 9.49 and 5.45 cm2/pimol, respectively.
These values were independent of the pH in range 7—9.
The substrates i-7rglutamyl-3-carboxy<4-nitranilide and
jt-y-glutamyl-3-sulphonic-4-nitranilide show no measur-
able absorbance at wavelengths higher than 410 nm.
The absorption maxima of these Ζ,-γ-glut myl-p-
nitranflide derivatives in Tris buffer are 317 nm (molar
absorptivity: 11.7 cm2//iimol) and 290 nm (molar absorp-
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Tab. 1. Solubilities and relative activities at a concentration of 4
 mmol/l of various derivatives of L-y-glutamyl-p-nitranuide in Trisbuffer (200 mmol/l, pH 8.2) containing glycylglycine (40 mmol/l). ««anurae in ins
Groups of structure substituents
COOH R = -SO3H; -COOH
solubility relation rate of hydro-
lysis; £-7-glutamyl-p-
nitranilide = 100%
> 300 mmol/l inhibitory
CH-NH2
1
CH2
1
*,
^ /ΛCO-HN-f VNO2 R = -OH; -CH3 ; -Cl
COOH R = -SO3H; -COOH
£ 10 mmol/l low; ^  45 %
> 300 mmol/l ^100%
CH-NH2I
CH2
CH2
1
R = -Cl; -OH; -OCH2
-COOH; -CONH2; -OCH3
3® R' = ~H
/ΗΓ R = -COOH
CO-HN- ff VN02 R' = -CH3
<10 mmol/l ^ 2 5 %
> 100 mmol/l 35-40%
COOH
CH-NH2
CH2
1
CH2
CO-H
Α ι
1.500
1.000
0.500
0
ΝΌ"κ°2
_^
X'-'X/ \/ \
s~\ // V \/ v \/ Λ ^/ \ v
\ / \V \\
. . ι .. . _ j... .. ^N^^ V^ -
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Fig. 1
X f n m ]
. Absorption spectrum of jL-7-glutamyl-3-carboxy-4-
nitraniiide in Tris b ffer (pH 8.2, 200 mmol/l). For com-
parison: the absorption spectrum of 2-nitto-5-aminp-
benzoic acid :(- - ^).
tivity: 4.57 cm2/Atmol) respectively. The absorption
pattern of jL-y-glutamyl-3-carboxy-4-nitranilide is shown
in Figure 1.
= 4 mmol/l 20%
Optimal condition
The dependence of γ-glutamyltransferase on pH with
both substrates was tested in various buffers. The optimal
pH in Tris-HCl buffer was between 8.1 and 8.3 foiL·
7-glutamyl-3-carboxy-4-nitranilide and between 8.2 and
8.4 forZ,-7-glutamyl-3-sulphonic-4-nitranilide (fig. 2).
An identical curve was obtained in ammediol-HCl buffer
(100 mmol/l), but activities were slightly lower. At
37 °C the optimal pH value is nearly the same. Tris-HCl
buffer was taken as the buffer of choice due to its opti-
mal buffering capacity in this pH-range (pKa = 8.1). The
influence of the concentration of Tris buffer on enzymic
activity is shown in figure 3. A concentration of 100
mmol/l was as a rule used in the other experiments.
The optimal concentration of glycylglycine as acceptor
was about 150 mmol/l both at 25°C and 37°C. Examples
are presented in figures 4 and 5.
The highest activities were measured at substrate concen-
trations between 4 and 8 mmol/l. Higher substrate
concentrations caused inhibition of activity (fig. 5).
Optimal activities can therefore not be measured at
substrate concentrations which equal 40 X Km. The
J. Clin. Chem. Clin. Biochem. / Vol. 14,1976 / No. 9 30*
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Fig. 2. Dependence of 7-glutamyltransferase activity upon pH
using L-7-glutamyl-3-sulphonic-4-nitranilide (o o) or
Z,-7^1utamyl-3-carboxy^-nitranilide (· - o) in concen-
trations of 8 mmol/1.
Measurements in Tris HC1 buffer (100 mmol/1) and Gly-
cylglycine (100 mmol/1).
All these experiments were carried out with the same
serum.
Fig. 3. Enzyme activity as a function of concentration of Tris
HC1 buffer (pH 8.2). Substrate: Z,-7-glutamyl-3-sulphonic-
4-nitranilide (o ο, β mmol/1) or jL-7-glutamyl-3-carboxy-
4-nitranilide (·-—·, 6 mmol/1). Incubation medium con-
tained glycylglycuie (100 mmql/1). All these experiments
were carried out with the same serum.
120
^ 80
S 40
I
200 400 600 800
Glycylglycine [mmol/l]
1000 6 6 10
[SJ [mm l/l]
12 14
Fig. 4. Enzyme activity withjL-7-glutamyl-3-carboxy-4-nitramlide
(8 mmol/1) as a function of concentration of glycylglycine
in Tris buffer (pH 8.2,100 mmol/1). These experiments
were carried out with two different sera.
Fig. 5. Effect of substrate concentration on 7-glutamyltransferase
activity. Open signs refer to I-7-glutamyl-3-sulphonic-4-
nitranilide, filled signs to Zr-7^1utamyl-3-caiboxy-4-nitrani-
lide in the presence of glycylglycine, 50 mmol/1 (rectang-
les), 100 mmol/1 (triangles) and 150 mmol/1 (circles).
All these experiments were carried out with the same
serum.
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selected optimal conditions were: Tris-HCl buffer
100 mmol/1 (pH 8.2 for£-7-glutamyl-3-carboxy-4-
nitranUide and pH 8.3 for Z,-7-glutamyl-3-sulphonic-4-
nitranilide), substrate 6 mmol/1 and glycylglycine
150 mmol/1.
Evaluation of the method
Relationship between absorbance and enzyme level
Serum activities with Z,-7-glutamyl-3-carboxy-4-nitranilide
and Z,-?-glutamyl-3-sulphonic-4-nitranilide are directly
proportional to the amount of serum (fig. 6). Heat-
inactivated serum as well as physiological saline were
used as diluents in the experiments. An identical result
was obtained at an incubation temperature of 37°C.
Influence of temperature
The temperature dependence of serum activity with
L-7-giutamyl-3-carboxy-4-nitranilide and L-7-glutamyl-
3-sulphonic-4-nitranilide was studied in the range
25-41 °C. A linear relationship between logarithms of
activity and reciprocals of absolute temperature was
found to exist between 25°C and 30°C. Above 30°C,
deviation from linearity was more marked in the case
of Z,-7-glutamyl-3-carboxy-4-nitranilide (fig. 7).
Comparative studies
In twenty-nine sera, γ-glutamyltransferase was measured
according to Szasz (6) as well as with the substrates
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Fig. 6. Relation of enzyme concentration to yglutamyltians-
ferase activity as measured with L-7-glutamyl-3-sulphonic-
4-nitranilide (o o) or /,"y-glutamyl-3-carboxy-4-nitra-
nilide (· ·) under optimal conditions. Dilutions were
made up with heat inactivated serum (circles) or physio-
logical saline (rectangles).
I-7-glutamyl-3-carboxy-4-nitranilide and L-7-glutamyl-3-
sulphonic-4-nitranilide (under optimal conditions). The
results shown in figure 8 demonstrate that the activity
obtained with£-7-glutamyl-3-sulphonic-4-nitranilide was
1.89 times and that obtained with jOy-glutamyl-3-carboxy-
4-nitranilide was 1.22 times that obtained according to
Szasz.
400
»300
"σ
S
φ 200
1 150
5
3
3
«k
100 \ I
338318
Temperature (ΙΟ^Κ'1]
Fig. 7. Dependence of rglutamyltransferase activity upon temper-
ature of incubation; plotted according to Arrhenius.
Substrate: £-y-glutamyl-3-sulphonic-4-nitranilide
(o - o) or L-7-glutamyl-3-carboxy-4-nitranilide (· - ·).
0 50 100 150
y-Glutomyl transferose 10/11(25*0
Fig. 8. Comparison of 7-glutamyltransferase activities measured
with £-7-glutamyl-3-carboxy-4-nitranilide (· ·) or
£-7-glutamyl-3-sulphonic-4-nitranilide (o o) under
optimal conditions with those obtained with the method
according to Szasz (plotted on the ordimte) using L-y-
glutamyl-p-nitranilide.
γ (ΐ,-γ-glutamyl-p-nitranilide) = 0.82138 X (jL-^-glutamyl-
3-carboxy-4-nitranilide) -0.62195 (r = 0.99929).
Υ (L-rglutamyl-p-nitranilidc) = 0.52868 X (£-rglutamyl-
3-sulphonic-4-nitranilide) -0.52121 (r = 0.99688).
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Accuracy
The coefficients of variation (C.V.) of γ-glutamyltrans-
ferase as measured with I-7-glutamyl-3-carboxy-4-
nitranilide were 4.2% for the range 20-40 U/l (n = 50)
and 1.0% for the range 100-140 U/l (n = 40). They were
calculated from duplicates of assays, performed during
a period of about six months, by the formula
Ν
in the presence of glycylglycine, glycine has an inhibit-
ory effect. An identical curve was obtained at 37°C.
Interference by hemolysis
A haemoglobin concentration lower than 3 g/1 (0.19
mmol/1) serum does not interfere with the reaction.
Higher haemoglobin concentrations result in a decreased
enzymic activity, the decrease being about 20% at 5 g/1
(0.31 mmol/1) serum.
Interference by L-glutamic acid or L-j-glutamyl-2-
carboxy-4-nitranilide
Experiments with L-glutamic acid, which reportedly
increases γ-glutamyltransferase (21), have been described
elsewhere in detail (22). Briefly, no increase in activity
was found when i-glutamic acid was incorporated in the
test media at concentrations of 10-5000 μπκ>1/1.
γ-Glutamyltransferase is inhibited* competitively by L-y~
glutamyl-2-carboxy-4-nitranilide. The activity found at
a concentration equimolar to Z,-7-glutamyl-3-carboxy-4-
nitranilide (i. e. 6 mmol/1) was about 20% lower.
Interference by glycine
In determining the optimal glycylglycine concentration
with various preparations, one preparation showed a
marked decrease in γ-glutamyltransferase at higher con-
centrations than that indicated in figure 4. Gaschromato-
graphic analysis revealed pollution of this preparation
with glycine. The effect of glycine was consequently
studied and the results presented in figure 9 show that,
5 10 15 20
Glycine [mmol/l]
Fig. 9. Effect of glycine on γ-glutamyltransferase activity
measured with L^y-glutamyl-3-carboxy-4-nitranilide
(· ·) or jL-rglutamyl-3-sulphonic-4-nitranilide(o o) under optimal conditions.
Concluding Remarks
The method proposed has the advantages of the method
in current use, i. e. the Szasz method (6) and applies
a new substrate characterized by high solubility and an
acceptable molar absorptivity of the cleavage product.
The method is therefore simpler, because various more
or less complicated attempts to prepare substrate solu-
tions at optimal concentration, as with Ζ,-γ-glutamyl-
p-nitranilide, are not required. The data in figure 8
warrant the conclusion, moreover, that the clinical signi-
ficance of γ-glutamyl-transferase, as established by
various authors using Z-y-glutamyl^p-nitranilide (7-16),
can be maintained when the proposed method is applied.
We prefer Z^-glutamyW-carboxy^-nitranilide for the
following reason. The fact that higher activities are
measured with i-y-glutamyl-S-sulphonic^^nitranilide
than withZr7-glutamyl-3-carboxy4-nitranilide is of no
advantage because the absorption coefficient of the
coloured cleavage product of Z,-7-glutamyl-3-sulphonic-
4-nitranilide is substantially lower.
To give an example: table 2 presents the activities and
corresponding ΔΑ/min values obtained with the sub-
strates Z,-7-glutamyl-3-carboxy-4-nitranilide and Ζ,-γ-
glutamyl-3-sulphonic-4-nitranilide in a serum which
according to Szasz had a γ-glutamyltransferase of
100 U/l. All ΔΑ/min values in table 2 refer to an iden-
tical amount of serum (0.2 ml), added to an identical
amount of buffered substrate (3 ml). The data show that
the ΔΑ/min with which the γ-glutamyl-transferase is
measured in the borderline region between normal and
pathological is more favourable with Z,-7-glutarnyl-3-
carboxy-4-nitranilide than with Z,-7-glutamyl-3-sulphonic-
4-nitranilide.
Tab. 2. Comparison of activities and corresponding initial
changes of absorbance (1.0 cm light path).
A 405 nm/
min1)
100 U/l according to Szasz (6) method 0.062
122 U/l with £-T-glutamyl-3^carboxy-4-nitranuide2) 0.071
189 U/l with I-7-glutamyl-3-sulphonic-4-nitranilidea) 0.059
*) 3 ml buffer substrate
0.2 ml serum2) measured under optimal conditions
J. Clin. Chem. Clin. Biochem. / Vol. 14,1976 / No. 9
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We therefore propose the procedure using ,- -glutamyl-
3-carboxy-4-nitranilide as the method of choice under
the conditions described in Materials and Methods.
Glycine-free glycylglycine should be used.
The advantages described above make it possible to
adapt the assay to any kind of automation without
changing the conditions.
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